PARASASSI TIZIANA
No ORCID on file
· 21 papers in corpus
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…
2011
The invention relates to a new prescription of NAC in the treatment of endometriosisand of indications associated withendometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of en…